June 18, 2014Open Access

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Key Points

Key points are not available for this paper at this time.

Abstract

Loss-of-function mutations in APOC3 were associated with low levels of triglycerides and a reduced risk of ischemic cardiovascular disease. (Funded by the European Union and others.).

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Jørgensen et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69cdfe8c3d84e1f5ff46c484 — DOI: https://doi.org/10.1056/nejmoa1308027

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.· 1991 · 208 citations
Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in Humans· 2006 · 222 citations
Pre-mRNA splicing and human disease· 2003 · 1,260 citations
Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families· 2013 · 23 citations

Authors

Anders Berg Jørgensen

Ruth Frikke‐Schmidt

Børge G. Nordestgaard

Journals

New England Journal of Medicine

Actions

Institutions

University of Copenhagen

Rigshospitalet

Copenhagen University Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion